Cision PR Newswire

AccidentAccidentAir PollutionAll NewsAnnoucementArgricultureArtASEANBook

Basecamp Research raises $140M to advance AI-designed therapeutics

/C O R R E C T I O N -- Basecamp Research/ In the news release, Basecamp Research raises $140M to advance AI-designed therapeutics,...

Gastops and Vestas Renew Agreement for MetalSCAN Oil Debris Monitoring Technology

HAMBURG, Germany, Sept. 25, 2026 /PRNewswire/ -- Gastops, a global leader in intelligent condition...
Cision PR Newswire

ELEGRP Showcases HF GFCI Receptacle and Comprehensive GFCI Solutions at NECA 2026

LAS VEGAS, Sept. 25, 2026 /PRNewswire/ -- October 4–7, 2026 — ELEGRP today announced...
Cision PR Newswire

EUHOMY CLOSES IFA 2026 WITH NINE HONORS ACROSS ITS ICE MAKER LINEUP

Rock Pro, Ice Leopard X1 and Pearl L1 Max recognized by IFA Berlin and...
Cision PR Newswire

Hong Kong’s First Board-Certified Veterinary Nutritionist-Developed Brand Mylo Officially Launches

Microbiome Research Confirms Inhibiting 95% of Harmful Bacteria, Collaborating with Local University Teams to...
Cision PR Newswire

DIGITIMES Intelligence: Chip Controls Are Reshaping China’s Auto Supply Chain — BYD Shows What Comes Next

TAIPEI, Sept. 7, 2026 /PRNewswire/ -- The global automotive industry is entering a new phase in which semiconductors are becoming as strategically important as...

Rznomics Reports Major Advances in High-Efficiency Circular RNA Production in Nucleic Acids Research

SEONGNAM,...

Ascletis Announces Inclusion in the Hong Kong Stock Connect List under the Shanghai-Hong Kong Stock Connect and the Shenzhen-Hong Kong Stock Connect Programs

HONG...

Clover Announces Positive Phase 2 Clinical Data for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates in Older Adults

-- Positive Phase 2 (Australia) results strengthen potential best-in-class profile of RSV+hMPV±PIV3 combination vaccines, with the potential differentiated ability to re-vaccinate individuals previously receiving...

Fosun Pharma Announces H-Share Repurchase Plan of Up to HK$ 1 Billion

SHANGHAI, Sept. 7, 2026 /PRNewswire/ -- Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma", stock code: 600196.SH; 02196.HK) today announced an H-share repurchase plan, under...

VITG Unveils Modern Managed Services and Managed Detection & Response as Part of a Broader AI and Cybersecurity Transformation across ANZ

SYDNEY,...
1...505152...4,388Page 51 of 4,388